Profile of:

Raj Sengupta

Full name: Raj Sengupta

Current country: United Kingdom

Membership level: Full

Type of membership: Member

Number of publications: 64

The natural history of chronic widespread pain in patients with axial spondyloarthritis: a cohort study with clinical and self-tracking data (2023)

Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope (2023)

ASAS consensus definition of early axial spondyloarthritis (2023)

Protocol for a systematic literature review of smartphone apps to support the self-management of rheumatic and musculoskeletal diseases: development strategies, theoretical underpinnings and barriers to engagement (2023)

Diagnostic delay in axial spondylarthritis: A lost battle? (2023)

Real-world evidence for secukinumab in UK patients with psoriatic arthritis or radiographic axial spondyloarthritis: interim 2-year analysis from SERENA (2023)

The Future of Axial Spondyloarthritis Rehabilitation: Lessons Learned From COVID‐19 (2022)

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit (2022)

The natural history of chronic widespread pain in patients with axial spondyloarthritis: a cohort study with clinical and self-tracking data (2022)

Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review (2022)

Determinants of Longitudinal Adherence in Smartphone-Based Self-Tracking for Chronic Health Conditions: Evidence from Axial Spondyloarthritis (2021)

A novel IMU-based clinical assessment protocol for Axial Spondyloarthritis: a protocol validation study (2021)

Understanding flare in axial spondyloarthritis: novel insights from daily self-reported flare experience (2021)

Practical Approaches to Bone Marrow Fat Fraction Quantification Across Magnetic Resonance Imaging Platforms (2020)

BRITSpA at five (2020)

Real-world experience of secukinumab treatment for ankylosing spondylitis at the Royal National Hospital for Rheumatic Diseases, Bath (2020)

Evaluating patient-reported fatigue and serum biomarkers in axial spondyloarthritis (2020)

The Future of Axial Spondyloathritis Treatment (2020)

Response to lower dose TNF inhibitors in axial spondylarthritis; a “real world” multicentre observational study (2020)

Back pain, ankylosing spondylitis and social media usage; a descriptive analysis of current activity (2020)

Physical therapy in axial spondyloarthritis: guidelines, evidence and clinical practice (2020)

Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5 (2020)

Evaluation of a patient self-stratification methodology to identify those in need of shielding during COVID-19 (2020)

Axial spondyloarthritis 10 years on: still looking for the lost tribe (2020)

Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study (2020)

Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey (2020)

Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study (2019)

Association of Diverticulitis with Prolonged Spondyloarthritis: An Analysis of the ASAS-COMOSPA International Cohort (2019)

Exploring the Future Role of Self-Tracking Data in the Rheumatology Clinic (2019)

AxSpA patients who also meet criteria for fibromyalgia : identifying distinct patient clusters using data from a UK national register (BSRBR-AS) (2019)

Exploring sub-optimal response to tumour necrosis factor inhibitors in axial spondyloarthritis (2019)

Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK (2019)

Use of Complementary and Alternative Medicine in Axial Spondyloarthritis: A Qualitative Exploration of Self-Management (2019)

Living with Ankylosing Spondylitis: An open response survey exploring physical activity experiences. (2019)

(Un)Spoken realities of living with axial spondyloarthritis: a qualitative study focused on couple experiences (2019)

Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy (2019)

Awareness of axial spondyloarthritis among chiropractors and osteopaths: findings from a UK Web-based survey (2019)

A truly complementary approach: A qualitative exploration of complementary and alternative medicine practitioners’ views of treating ankylosing spondylitis (2018)

The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis (2018)

Short-term Repeat Magnetic Resonance Imaging Scans in Suspected Early Axial Spondyloarthritis Are Clinically Relevant Only in HLA-B27-positive Male Subjects (2018)

Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort (2018)

Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood (2018)

Biologics for treating axial spondyloarthritis (2018)

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register (2018)

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis — findings from a United Kingdom cohort: Reply (2018)

Monitoring patients with ankylosing spondylitis on anti-TNF monotherapy: too much too often? (2017)

Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis (2017)

Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents? (2017)

Fatigue contributes to work productivity impairment in patients with axialspondyloarthritis: a cross-sectional UK study (2017)

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: A prospective cross-sectional comparative study (2017)

Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) Meeting (2017)

Prevalence and factors associated with disturbed sleep in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review. (2016)

BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics (2016)

Clinical outcomes and progression to orthopaedic surgery in juvenile versus adult-onset ankylosing spondylitis (2015)

Serum Soluble Bone Turnover Biomarkers in Psoriatic Arthritis and Psoriatic Spondyloarthropathy (2015)

Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? (2015)

Comment on: delay to diagnosis in axial spondyloarthritis: are we improving in the UK?: (2015)

Reliability, feasibility and sensitivity of four peripheral radiographic scores for PsA. (2014)

Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. (2013)

Expanding the spectrum of inflammatory spinal disease: AS it was, as it is now. (2013)

Juvenile Versus Adult-onset Ankylosing Spondylitis — Clinical, Radiographic, and Social Outcomes. A Systematic Review (2013)

Challenges in the management and research of juvenile onset ankylosing spondylitis (2013)

Assessment of impact of flares in ankylosing spondylitis disease activity using the flare illustration (2008)

The assessment of ankylosing spondylitis in clinical practice. (2007)